Literature DB >> 26524664

Coexistence of Mayer-Rokitansky-Küster-Hauser Syndrome and Turner Syndrome: A Case Report.

Agnieszka Białka1, Aneta Gawlik2, Agnieszka Drosdzol-Cop3, Krzysztof Wilk1, Ewa Małecka-Tendera2, Violetta Skrzypulec-Plinta1.   

Abstract

BACKGROUND: Turner syndrome is a common chromosomal disorder, with an incidence of 1 in 2000 live-born female infants. Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) affects 1 in 4500 female births and, rarely, it might be associated with gonadal dysgenesis. CASE: A 17-year-old girl was referred to our clinic with short stature and primary amenorrhea. The patient was diagnosed with Turner syndrome and underwent estrogen therapy. At the age of 24 years, just after the patient's sexual initiation, the first complete gynecological examination was performed. A blind-ending vagina was revealed and the patient was diagnosed with MRKH. SUMMARY AND
CONCLUSION: Early diagnosis of coexistence of MRKH and Turner syndrome, although very difficult, might prevent patients from developing serious complications.
Copyright © 2016 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gonadal dysgenesis; Mayer-Rokitansky-Küster-Hauser syndrome; Turner syndrome

Mesh:

Substances:

Year:  2015        PMID: 26524664     DOI: 10.1016/j.jpag.2015.10.019

Source DB:  PubMed          Journal:  J Pediatr Adolesc Gynecol        ISSN: 1083-3188            Impact factor:   1.814


  3 in total

1.  Primary amenorrhoea secondary to two different syndromes: a case study.

Authors:  Zareen Kiran; Tayyaba Jamil
Journal:  BMJ Case Rep       Date:  2019-03-15

2.  Unusual association of Turner syndrome and Mayer-Rokitansky-Küster-Hauser syndrome.

Authors:  Alpana Meena; Mradul Kumar Daga; Rashmi Dixit
Journal:  BMJ Case Rep       Date:  2016-05-20

Review 3.  Primary Amenorrhea Due to Anatomical Abnormalities of the Reproductive Tract: Molecular Insight.

Authors:  Karina Kapczuk; Witold Kędzia
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.